uni-leipzig-open-access/json/a-2063-3247

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T04:39:59Z","timestamp":1685075999507},"reference-count":6,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tierarztl Prax Ausg K Kleintiere Heimtiere"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Im Jahr 2022 kamen f\u00fcr Kleintiere 3 neue Wirkstoffe auf den deutschen\n                    Tierarzneimittelmarkt: der periphere selektive\n                    \u03b12-Adrenozeptor-Antagonist Vatinoxan in Kombination mit\n                    Medetomidin (Zenalpha\u00ae), mesenchymale Stammzellen aus der Nabelschnur\n                    von Pferden (DogStem\u00ae) und das Ektoparasitikum Tigolaner in\n                    Kombination mit Emodepsid und Praziquantel (Felpreva\u00ae). Kein\n                    Wirkstoff erhielt eine Tierartenerweiterung. Des Weiteren kamen f\u00fcr\n                    Kleintiere auf den Markt: Vier Wirkstoffe (Acetylcystein, Clindamycin,\n                    Metoclopramid, Oclacitinibmaleat) in einer neuen Darreichungsform, ein Wirkstoff\n                    mit einem neuen Wirkstoffgehalt (Firocoxib) und eine neue Wirkstoffkombinationen\n                    in einer neuen Darreichungsform\n                    (Ketoconazol+Marbofloxacin+Prednisolon).<\/jats:p>","DOI":"10.1055\/a-2063-3247","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T22:56:24Z","timestamp":1685055384000},"page":"116-122","source":"Crossref","is-referenced-by-count":0,"title":["Neue Arzneimittel f\u00fcr Kleintiere 2022"],"prefix":"10.1055","volume":"51","author":[{"given":"Ilka Ute","family":"Emmerich","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pharmakologie, Pharmazie und Toxikologie,\n                    Veterin\u00e4rmedizinische Fakult\u00e4t der Universit\u00e4t\n                    Leipzig"}]}],"member":"194","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"ref3","doi-asserted-by":"publisher","first-page":"13437","DOI":"10.3390\/ijms150813437","article-title":"Hip Osteoarthritis in Dogs: A Randomized Study Using Mesenchymal Stem Cells from\n                    Adipose Tissue and Plasma Rich in Growth Factors","volume":"15","author":"B Cuervo","year":"2014","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1746-6148-10-143","article-title":"Assessment of the effect of intraarticular injection of autologous\n                    adipose-derived mesenchymal stem cells in osteoarthritic dogs using a double\n                    blinded force platform analysis","volume":"10","author":"J M Vilar","year":"2014","journal-title":"BMC Vet Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2460\/javma.22.06.0237","article-title":"Equine umbilical cord mesenchymal stem cells demonstrate safety and efficacy in\n                    the treatment of canine osteoarthritis: a randomized placebo-controlled\n                    trial","volume":"260","author":"E Punz\u00f3n","year":"2022","journal-title":"JAVMA"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"100099","DOI":"10.1016\/j.crpvbd.2022.100099.","article-title":"Multicenter randomized, and blinded European field study evaluating the efficacy\n                    and safety of Felpreva\u00ae, a novel spot-on formulation\n                    containing emodepside, praziquantel and tigolaner, in treating cats naturally\n                    infested with fleas and\/or ticks","volume":"2","author":"D Cveji\u0107","year":"2022","journal-title":"Curr Res Parasitol Vector Borne Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"100098","DOI":"10.1016\/j.crpvbd.2022.100098.","article-title":"Multicenter randomized, and blinded European field study evaluating the efficacy\n                    and safety of Felpreva\u00ae, a novel spot-on formulation\n                    containing tigolaner, emodepside and praziquantel, in treating cats with mixed\n                    infection with intestinal nematodes, cestodes and\/or lungworms","volume":"2","author":"D Cveji\u0107","year":"2022","journal-title":"Curr Res Parasitol Vector Borne Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2460\/ajvr.80.10.912","article-title":"Cardiovascular and sedation reversal effects of intramuscular administration of\n                    atipamezole in dogs treated with medetomidine hydrochloride with or without the\n                    peripheral \u03b12-adrenoceptor antagonist vatinoxan hydrochloride","volume":"80","author":"H Turunen","year":"2019","journal-title":"Am J Vet Res"}],"container-title":["Tier\u00e4rztliche Praxis Ausgabe K: Kleintiere \/ Heimtiere"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2063-3247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T22:57:46Z","timestamp":1685055466000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2063-3247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":6,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2023,5,25]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"http:\/\/dx.doi.org\/10.1055\/a-2063-3247","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1434-1239","2567-5842"],"issn-type":[{"value":"1434-1239","type":"print"},{"value":"2567-5842","type":"electronic"}],"subject":["Small Animals"],"published":{"date-parts":[[2023,4]]}}}